Unknown

Dataset Information

0

Pharmacokinetics of bisphenol A in humans following a single oral administration.


ABSTRACT:

Background

Human exposures to bisphenol A (BPA) are widespread. The current study addresses uncertainties regarding human pharmacokinetics of BPA.

Objective

To reduce uncertainties about the metabolism and excretion of BPA in humans following oral administration.

Methods

We exposed six men and eight women to 100 μg/kg bw of deuterated BPA (d6-BPA) by oral administration and conducted blood and urine analysis over a three day period. The use of d6-BPA allowed administered d6-BPA to be distinguished from background native (unlabeled) BPA. We calculated the rate of oral absorption, serum elimination, half-life, area under the curve (AUC), urinary excretion, and metabolism to glucuronide and sulfate conjugates.

Results

Mean serum total (unconjugated and conjugated) d6-BPA Cmax of 1711 nM (390 ng/ml) was observed at Tmax of 1.1 ± 0.50h. Unconjugated d6-BPA appeared in serum within 5-20 min of dosing with a mean Cmax of 6.5 nM (1.5 ng/ml) observed at Tmax of 1.3 ± 0.52 h. Detectable blood levels of unconjugated or total d6-BPA were observed at 48 h in some subjects at concentrations near the LOD (0.001-0.002 ng/ml). The half-times for terminal elimination of total d6-BPA and unconjugated d6-BPA were 6.4 ± 2.0 h and 6.2 ± 2.6h, respectively. Recovery of total administered d6-BPA in urine was 84-109%. Most subjects (10 of 14) excreted >90% as metabolites within 24h.

Conclusions

Using more sensitive methods, our study expands the findings of other human oral pharmacokinetic studies. Conjugation reactions are rapid and nearly complete with unconjugated BPA comprising less than 1% of the total d6-BPA in blood at all times. Elimination of conjugates into urine largely occurs within 24h.

SUBMITTER: Thayer KA 

PROVIDER: S-EPMC4545316 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>Human exposures to bisphenol A (BPA) are widespread. The current study addresses uncertainties regarding human pharmacokinetics of BPA.<h4>Objective</h4>To reduce uncertainties about the metabolism and excretion of BPA in humans following oral administration.<h4>Methods</h4>We exposed six men and eight women to 100 μg/kg bw of deuterated BPA (d6-BPA) by oral administration and conducted blood and urine analysis over a three day period. The use of d6-BPA allowed administered d6  ...[more]

Similar Datasets

| S-EPMC9210257 | biostudies-literature
| S-EPMC6044034 | biostudies-literature
| S-EPMC6149762 | biostudies-other
| S-EPMC9736016 | biostudies-literature
| S-EPMC8855120 | biostudies-literature
| S-EPMC5826115 | biostudies-literature
| S-EPMC9931020 | biostudies-literature
| S-EPMC9047015 | biostudies-literature
| S-EPMC9292235 | biostudies-literature
| S-EPMC4238735 | biostudies-literature